Cargando…
New generation breast cancer cell lines developed from patient-derived xenografts
BACKGROUND: Breast cancer is a highly heterogeneous disease characterized by multiple histologic and molecular subtypes. While a myriad of breast cancer cell lines have been developed over the past 60 years, estrogen receptor alpha (ER)+ disease and some mutations associated with this subtype remain...
Autores principales: | Finlay-Schultz, Jessica, Jacobsen, Britta M., Riley, Duncan, Paul, Kiran V., Turner, Scott, Ferreira-Gonzalez, Andrea, Harrell, J. Chuck, Kabos, Peter, Sartorius, Carol A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310532/ https://www.ncbi.nlm.nih.gov/pubmed/32576280 http://dx.doi.org/10.1186/s13058-020-01300-y |
Ejemplares similares
-
Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a
por: Finlay-Schultz, Jessica, et al.
Publicado: (2014) -
Cytokeratin 5 alters β-catenin dynamics in breast cancer cells
por: McGinn, Olivia, et al.
Publicado: (2020) -
Identification of synergistic drug combinations using breast cancer patient-derived xenografts
por: Turner, Tia H., et al.
Publicado: (2020) -
Estrogens and Progestins Cooperatively Shift Breast Cancer Cell Metabolism
por: Ward, Ashley V., et al.
Publicado: (2022) -
Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways
por: Iwanaga, Ritsuko, et al.
Publicado: (2012)